/KASE, November 24, 2017/ – Chimpharm (Shymkent), whose shares are officially listed on Kazakhstan Stock Exchange (KASE), has notified KASE of a KZT73,783,301.02 loan received on November 22, 2017 (in Kazakh and Russian) – see more

[2017-11-24]